glp-1 treatment new orleans Medically Supervised Weight Loss Researchers Unite in New Orleans

00:15:07 Craig Williams So weve probably all had some experience with patients who can successfully come off of them and at least not regain all the weight, maybe maintain at some level they want to

Tommey AM, Shi J, Lindsay WP, Urwin PE, Robinson NJ

Patients with morbid obesity and GLP-1 receptor agonist exposure also had a significantly lower risk for exacerbations compared with those without exposure (risk difference, 13.3%

International sourcing adds another layer of complexity

Duration Guidelines Based on Clinical Evidence Current medical guidelines recommend continuing GLP-1 therapy indefinitely for patients with obesity or weight-related metabolic conditions, similar to how blood pressure or cholesterol medications are managed long-term